BioCentury
ARTICLE | Company News

Oncor, Tel Aviv University deal

July 22, 1996 7:00 AM UTC

ONC received an exclusive worldwide license from the university to a p43 blood test for detecting early stage breast cancer. Studies suggest that the measure of p43 can be an accurate predictor of tum...